
Anjana Pillai
@anjanapillaimd
Professor @UChicagoMed specializing in liver tumors and Liver Tx|#LDLT|PD Transplant Hep Fellowship|Director @HCCLIVEConf |Mommy of 2|Educator|Runner
ID: 1193632552029958149
https://www.uchicagomedicine.org/cancer/types-treatments/liver-cancer 10-11-2019 20:52:44
2,2K Tweet
2,2K Followers
632 Following

Tumor board part DEAUX- iCCA and rapid 🔥 complex HCC cases run by the experts Julie Heimbach and Riad Salem Look at this all ⭐️ panel- great learning on how to run your own UChicagoIR Dr. Nina Niu Sanford Tanios Bekaii-Saab, MD Ed Kim Anthony El-Khoueiry Lizzie Aby, MD


Honored to be with the man Karim J Halazun MD who ran through brick walls and used his incredible talents to save my life. Thank you HCC-LIVE Conference Anjana Pillai Blue Faery Global Liver Institute for having our family share our story in Austin. Today is 5 years. 🙏❤️


Histotrispy in HCC: new technology is exciting, but the data for histo just isn’t there (yet). Published studies mostly demonstrate technical feasibility, but long term clinical outcomes lacking, in addition to comparative data w other local modalities. 👍 talk HCC-LIVE Conference


Every year I feel so fortunate to be part of this #livercancer community with these amazing friends who are true leaders sharing a common goal! Amongst the beautiful chaos that is life, it’s important to find your passion and your people 🤍. That’s a wrap HCC-LIVE Conference!!


Tough role (but v honored) being the only rad onc at this meeting w HCC legends. Always learn a lot & have lots of fun Thanks to Anjana Pillai & Amit G Singal for inviting me to this great conference. (Also recorded interview w Josep Llovet - video coming soon 😀) HCC-LIVE Conference





🔥Nivolumab and Ipilimuma approved by EMA for advanced hepatocellular carcinoma 🔥 👇ec.europa.eu/health/documen… 👉great news for our patients > more options in 1st line 😅amazing: approval in 🇪🇺by EMA before 🇺🇸by FDA ESMO - Eur. Oncology EASL Education ILCA #livertwitter





🔥FDA approves nivolumab with ipilimumab for unresectable or metastatic MSI-H or dMMR colorectal cancer🔥 👉based on impressive efficacy in CHECKMATE-8HW ESMO - Eur. Oncology


Thank you to my friends CU Division of Gastroenterology and Hepatology for hosting me for #GI and transplant grand rounds to discuss the growing field of #transplantoncology! Big shout out to Whitney Jackson, MD, Michael Kriss, MD, Dr Jennifer Christie #JPNorvell for their hospitality!



A warm welcome to the 1⃣6⃣new members who joined #LICOP in March! We're thrilled to have you on board and look forward to the insights and energy you'll bring to our community.🙌 Lindsay Y King Anjana Pillai Howard T. Lee MD FAST Deepika Devuni MD Ashley Spann #LiverTwitter


Most cancers declining but continued rise in bile duct cancers in women - #NCI annual report Cholangiocarcinoma Foundation


Amazing Nazia Selzner - lucky to be inspired and surrounded by such strong women leaders

Did not fully appreciate all that is Singapore -although have wanted to do this trip for so long. What a pleasure to learn about both science and this stunning island for the last several days! Thank you Nazia Selzner and Valeria Mas, MSc,PhD, FAST for the invitation ILTS